onasemnogen abeparvovec

Spain

Drugs containing this active substance

  • ZOLGENSMA 2 X 10E13 VECTOR GENOMES/ML SOLUTION FOR INFUSION

    It is used to treat spinal muscular atrophy (SMA), which is a serious and rare hereditary disease.

    Form: solution for infusion

    Active substance Dosage
    onasemnogen abeparvovec 2 x 10e13 Genoma vectorial

    ATC: M09A M09AX M09AX09

    Manufacturer: Novartis Europharm Limited